| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.09 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.055 | 0.09 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.086 | 0.1 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |